Search results
Found 30423 matches for
A pioneering European research project aims to lead to new diagnostic tests to assess patients with non-alcoholic fatty liver disease (NAFLD) and identify those most at risk for developing severe inflammation and liver scarring. Researchers from the Oxford Centre for Clinical Magnetic Resonance Research will play a key role in evaluating a series of biomarkers for NAFLD.
Neubauer Group: Oxford Centre for Clinical Magnetic Resonance Research
OCMR uses sophisticated cardiac MR imaging and spectroscopy methods to phenotype cardiovascular disease – in small-scale proof-of-principle studies, large-scale multicentre clinical trials and ultra-large scale population imaging programmes. As well as running their own research programmes, OCMR serves as a collaboration partner to any group wanting to strengthen their clinical research with state of the art non-invasive phenotyping tools.
How to find us
How to find the Diabetes Trials Unit
Publications
DTU Publications
Tyler Group: Development and Application of Cardiac Magnetic Resonance Imaging and Spectroscopy
Using metabolic imaging to transform our approach to disease detection and treatment.
EVAREST (Echocardiography - Value and Accuracy at Rest and Stress)
EVAREST is CCRF-led multi-centre trial which aims to identify and validate novel blood and imaging biomarkers of potential value for consistent and accurate interpretation of stress echocardiography.
DPhil research opportunities
Find out about DPhil Research Opportunities available in 2020.